AAIC Investment is a Singapore-based fund management company established in 2013 as the investment arm of AAIC Holdings. The firm began by supporting Corporate Venture Capital activities of Japanese corporations in 2014 before pivoting to focus on Africa-focused investment opportunities. AAIC Investment manages two primary funds: the Africa Healthcare Fund (AHF1), launched in 2017, and the Africa Innovation and Healthcare Fund (AHF2), launched in 2022. The firm has invested in over 50 companies across Africa through its two funds as of early 2025, with a demonstrated focus on health technology and healthcare innovation. AAIC Investment's portfolio in East and West Africa reflects a strategic concentration in Kenya and Nigeria, where it has backed companies addressing critical healthcare access challenges. The investor targets companies across multiple stages, from early-stage ventures to Series A rounds, with particular emphasis on digital health platforms, pharmacy supply chain solutions, and healthcare delivery infrastructure that serve underserved populations across the continent.